PLUS1
8.225
0.035 (0.43%)
0.035 (0.43%)
Upgrade to Real-Time
Regular Market
Low
3.50
High
24.90
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.035 | 0.43% | 8.225 | 15:15:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 8.14 | 8.02 | 8.27 | 8.19 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 8.22 | 8.23 | 0.01 | 4 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,928 | 1,335,639 | $ 8.16 | $ 10,894,274 | - | 3.50 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:15:28 | 100 | $ 8.225 | USD |
Period:
Draw Mode:
Vaxart Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.01B | 122.82M | 122.10M | $ 4.05M | $ - | -0.35 | -16.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 580.63k | 2.40% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.65 | 9.40 | 7.93 | 8.54 | 3,610,336 | -0.425 | -4.91% |
| 1 Month | 8.41 | 9.496 | 7.70 | 8.68 | 3,837,219 | -0.185 | -2.2% |
| 3 Months | 8.35 | 10.33 | 6.56 | 8.26 | 7,636,522 | -0.125 | -1.5% |
| 6 Months | 6.89 | 11.108 | 4.862 | 8.38 | 13,501,867 | 1.34 | 19.38% |
| 1 Year | 6.40 | 24.90 | 3.50 | 8.40 | 13,836,311 | 1.83 | 28.52% |
| 3 Years | 2.81 | 24.90 | 0.2543 | 7.67 | 9,037,640 | 5.42 | 192.7% |
| 5 Years | 15.62 | 24.90 | 0.2543 | 7.66 | 5,605,301 | -7.40 | -47.34% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
